Raymond March Archive

Raymond J. March is a Research Fellow at the Independent Institute and Assistant Professor of Economics at San José State University. His research examines the public and private provision and governance of healthcare in the United States, particularly in pharmaceutical markets.

Let Competition, Not the FDA, Resolve the EpiPen Shortage



The only reliable remedy to mitigate shortages of any product is to allow competition in the market.

Government vs. Private Efforts to Promote Breastfeeding: My Response to a Critic



Private efforts to promote childhood nutrition (specifically breastfeeding) are superior to government “solutions.”

FDA Considers Regulating E-cigarette Juices



Despite the best of intentions, efforts to regulate vice frequently fail and can lead to harmful secondary effects for those they intend to help.

FDA Approves Medical App for Contraception



FDA behind the market in delivering contraceptive apps.

Open Up Off-Label Drug Communication and Let the Market Work!



Off-label information policy reform works to broaden what information drug providers can share.

Three Reasons To Be Optimistic about Pharmaceutical Policy



Right-to-try, MDMA, and Epidolex provide examples of the power of public opinion to change the scope of government.

If Telemedicine Is Underachieving, Government Is to Blame



Telemedicine providers have faced burdensome and complex regulatory structures at the state and federal level.

Putting Right-to-Try Drug Prices in Perspective



FDA regulation holds part of the blame for high drug prices.

EpiPen Pricing Controversy Reveals Ignorance about Market Competition



Increased competition is the remedy to skyrocketing drug prices.

Dear Congress, Please Don’t Keep Up with the Kardashians!



Kourtney Kardashian spoke on Capitol Hill in an attempt to motivate the federal government to play a larger role in regulating cosmetics. 

  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org